Researchers do not know how all the proteins and enzymes in the human body function, far from it. Now they have come a bit closer to understanding how an enzyme that appears to be important to cancer development behaves inside the cells.
The new study that has just been published in the scientific journal Nature Communications shows first of all that the enzyme methyltransferase (MTase)-like protein 13 (METTL13) helps control the formation of new proteins in the cells.
'Mistakes in the production of proteins are undesirable, as we know from other studies that it can result in the development of cancer tumors and degenerative brain disorders like Alzheimer's and Parkinson's. Therefore, the new knowledge of how this enzyme functions is significant', says the senior researcher.
The enzyme helps control protein synthesis by placing so-called methyl marks on a particular protein called eEF1A. Eukaryotic elongation factor 1 alpha (eEF1A) delivers aminoacyl-tRNA to the ribosome and thereby plays a key role in protein synthesis.
Human METTL13 contains two distinct MTase domains targeting the N terminus and Lys55 of eEF1A, respectively. The biochemical and structural analyses provide detailed mechanistic insights into recognition of the eEF1A N terminus by METTL13. Through ribosome profiling, authors demonstrate that loss of METTL13 function alters translation dynamics and results in changed translation rates of specific codons.
'If methyl is not attached correctly to the protein it will not be able to do its job properly. And that again affects the formation of proteins in the cell, which will take place at a suboptimal pace, and even though that may not sound so bad, it appears to be connected with very serious disorders', says the lead author.
The researchers have shown how the enzyme functions by studying isolated human cancer cells using advanced mass spectrometers which, in short, are able to identify and quantify proteins and their methyl-modifications in a cell.
Now the researchers hope the study will lead to the development of methods and drugs able to target and assure the enzyme to function as intended in our cells.
https://healthsciences.ku.dk/news/2018/09/researchers-uncover-previously-unstudied-cancer-enzyme/
https://www.nature.com/articles/s41467-018-05646-y
A new cancer target identified!
- 962 views
- Added
Edited
Latest News
Mutations in noncoding DNA…
By newseditor
Posted 24 Apr
More influence of environme…
By newseditor
Posted 24 Apr
The assembly of the human c…
By newseditor
Posted 24 Apr
Wiring of the human neocortex
By newseditor
Posted 24 Apr
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Other Top Stories
The gene to which we owe our big brain
Read more
Regulation and development of hematopoietic stem cells
Read more
Human brain organoids influence rat behavior
Read more
How neurons from PTSD patients react to stress
Read more
Common regulators of different direct reprogramming
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Massively parallel screen u…
By newseditor
Posted 24 Apr
Distinct genetic and enviro…
By newseditor
Posted 24 Apr
Hippocampus-to-amygdala pat…
By newseditor
Posted 24 Apr
Integrative spatial analysi…
By newseditor
Posted 24 Apr
Time-series reconstruction…
By newseditor
Posted 24 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar